Introduction {#s1}
============

The vast majority of human genomic variation is accounted for by Single Nucleotide Variants (SNVs) ([@B9]). The roughly 10,000 variants in the coding region of every human genome that have no effect on the resulting product protein sequence are termed synonymous SNVs (sSNVs) ([@B89]). sSNVs are a product of the degeneracy of genetic code, where amino acids may be encoded by more than one codon. The effects of sSNVs on molecular functionality of the corresponding genes/proteins are often assumed to be minimal. However, earlier studies have argued that sSNVs are as likely to be pathogenic as non-synonymous variants ([@B15]). sSNVs have been implicated in many diseases, including pulmonary sarcoidosis, attention deficit/hyperactivity disorder, and cancer ([@B81]; [@B100]). Synonymous variants can disrupt transcription ([@B99]), splicing ([@B70]), co-translational folding ([@B72]), mRNA stability ([@B75]) ([**Figure 1**](#f1){ref-type="fig"}), and cause a plethora of other functionally-relevant changes. In addition, sSNVs can affect transcription and splicing regulatory factors within protein coding regions ([@B73]), thus modulating gene expression ([@B85]; [@B8]). There is also evidence of evolutionary constraint on both synonymous and non-synonymous variants, which plays a role in shaping codon bias (organism or tissues-specific codon set preference) ([@B99]). An informative experimental approach to evaluating functional effects of sSNVs is saturation genome editing followed by protein function assays ([@B25]; [@B26]). Unfortunately, there are exceedingly few reports of these experiments in the literature. While there has been a concerted effort in the field to evaluate the effects of non-synonymous single nucleotide variants (nsSNVs) ([@B59]) for the purposes of precision medicine, as well as improving basic understanding of concepts in molecular biology, interpretation of sSNVs is severely lacking. However, considering the significant number of observed synonymous variants, their possible effects, and the dire lack of their systematic experimental interpretations, there is a compelling need for a reliable sSNV effect computational predictor.

![Possible mechanisms of sSNVs impact on biological function. Yellow triangles represent sSNV sites and the dashed lines indicate aberrant processes. sSNVs may affect **(A)** transcription factor binding, **(B)** splicing of pre-mRNA, **(C)** mRNA secondary structure and stability, **(D)** wobble-based tRNA binding, and **(E)** cotranslational folding (and thus the protein structure). Figure was created with BioRender.com.](fgene-10-00914-g001){#f1}

In this paper, we review the existing sSNV-effect predictors and apply them to a dataset containing *observed* and artificially *generated* sSNVs. Since there are few experimentally-determined SNVs with deleterious effects, and those that exist have been used as training or testing sets of the predictors, the cornerstone of this study is validating our data set assumption that deleterious sSNVs are enriched in the artificially *generated* set of variants. To support this assumption, in addition to previously published work, e.g., [@B99], we show that the distributions of observed sSNVs by amino acids and codons are highly non-random. We also demonstrate that existing predictor high-scoring variants are enriched among the artificially *generated* sSNVs, additionally validating of our assumption. We finally note that these predictors appear unable to definitely identify subtle effect sSNVs.

Methodology of the Predictors {#s2}
=============================

SNV Predictors Vary by Targeted Variant Type, Training Data, and Descriptive Features {#s2_1}
-------------------------------------------------------------------------------------

We identified from the literature four sSNV-specific effect predictors: SilVA (Silent Variant Analyzer) ([@B11]), regSNPs-splicing ([@B114]), DDIG-SN (Detecting Disease-causing Genetic SynoNymous variants) ([@B56]), and IDSV (Identification of Deleterious Synonymous Variants) ([@B91]). Additionally, we considered TraP (Transcript-inferred Pathogenicity) ([@B29]), which addresses both synonymous and intronic variants. Specifically, 1) SilVA was trained on 33 pathogenic and 785 neutral variants from 1000 Genomes Project (1000G) ([@B7]), using conservation scores, splicing, DNA, and RNA properties, 2) DDIG-SN and IDSV used positive data from the Human Gene Mutation Database (HGMD) ([@B18]; [@B96]; [@B98]; [@B97]) and negative data from 1000G (DDIG-SN) and VariSNP (IDSV) ([@B82]) as negative data for training, described using features of translational efficiency and protein properties in addition to those used by SilVA, 3) regSNPs-splicing also used HGMD and 1000G data, but it considers sSNVs only in the context of mRNA splicing and protein function, while 4) TraP was trained on positive data combining SilVA's data with Online Mendelian Inheritance in Man (OMIM) ([@B35]) variants and negative data from control trios *de novo* variants. TraP uses transcript-affecting features, specific to intronic and synonymous variants.

As opposed to the sSNV-specific tools, more generic predictors, including CADD ([@B44]), DANN ([@B76]), FATHMM-MKL ([@B92]), and MutationTaster2 ([@B83]), evaluate synonymous, non-synonymous, regulatory and other kinds of variants. CADD was developed by training a support vector machine (SVM) to differentiate observed *vs.* simulated variants of all variant categories ([@B44]). DANN attempts to capture nonlinear signals in (CADD-generated) variant data using a deep neural network ([@B76]). FATHMM-MKL is a Hidden Markov Model-based method integrating ENCODE ([@B17]) functional annotations of SNVs to evaluate non-coding and synonymous variants ([@B92]). MutationTaster2 ([@B83]) uses a naïve Bayes model trained on disease variants vs. variants from 1000G variants to evaluate all SNVs. Notably, these general-purpose predictors are heavily conservation-driven and may lack features to describe the subtle changes induced by sSNVs.

All predictors described here are machine learning-based \[using random forests (RFs), SVMs, or deep neural network\] and trained to predict pathogenicity, using different data and feature sets ([**Table 1**](#T1){ref-type="table"}). Supervised machine learning, often used for predicting variant effects, requires selecting a proper training/evaluation set, a number of relevant variant-, gene-, or disease-features, and an appropriate model for identifying feature patterns representative of variant effect/disease-association ([@B79]).

###### 

Summary of sSNV-specific predictors.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ref/Tool name             Training data                                                                          Model                                                           Features                                                        Performance
  ------------------------- -------------------------------------------------------------------------------------- --------------------------------------------------------------- --------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------
  ([@B11])\                 33 deleterious from literature, 785 neutral from one 1000 Genomes Project individual   Random forest with 1,001 trees and default number of features   26 in total\                                                    **Dataset**: 8 DM from literature and 752 NM from literature and 1000G.\
  SilVA (2013)                                                                                                                                                                      • conservation\                                                **Result**: DM's scores ranked higher than NM's
                                                                                                                                                                                    • RNA properties\                                              
                                                                                                                                                                                    • DNA properties\                                              
                                                                                                                                                                                    • Splicing                                                     

  ([@B29]) TraP (2017)      75 DM from literature and OMIM and 402 *de novo* NM from control trios                 Random forest with 1,000 trees, each with                       20 in total\                                                    **Dataset**: 66 DM and 4,418 NM from ClinVar.\
                                                                                                                                                                                    • Conservation\                                                **Result**: AUC = 0.88
                                                                                                                                                                                    • DNA properties\                                              
                                                                                                                                                                                    • Splicing                                                     

  ([@B114])\                ∼655 DM from HGMD and ∼655 NM from 1000G                                               Random forest with 51 trees and 35 features at each node        455 in total\                                                   **Dataset**: ∼325 DM from HGMD and 230 DM from ClinVar, ∼325 NM from 1000G and 4,535 NM from ClinVar\
  regSNPs-splicing (2017)                                                                                                                                                           • Conservation\                                                **Result**: For HGMD vs. 1000G data, AUC = 0.91 for variants in Splice Sites and AUC = 0.82 for all others\
                                                                                                                                                                                    • RNA properties\                                              For ClinVar data, AUC = 0.85 for variants in splice sites and AUC = 0.70 for the all others
                                                                                                                                                                                    • protein properties\                                          
                                                                                                                                                                                    • splicing                                                     

  ([@B56])\                 592 DM from HGMD and 10,925 putatively benign from 1000G                               Support Vector Machine with radial function kernel              54 in total (including all of the 26 features used in SilVA)\   **Dataset**: 279 DM from HGMD and 4,945 NM from 1000G\
  DDIG-SN (2017)                                                                                                                                                                    • conservation\                                                **Result**: AUC = 0.85
                                                                                                                                                                                    • DNA properties\                                              
                                                                                                                                                                                    • RNA properties\                                              
                                                                                                                                                                                    • Protein properties\                                          
                                                                                                                                                                                   Splicing                                                        

  ([@B91])\                 300 DM from dbDSM and 300 NM from VariSNP                                              Random forest with 500 trees and 3 features at each split       10 in total\                                                    **Dataset**: 153 DM and 5,178 NM from ClinVar\
  IDSV (2019)                                                                                                                                                                       • Conservation\                                                **Result**: AUC = 0.87
                                                                                                                                                                                    • DNA properties\                                              
                                                                                                                                                                                    • Splicing\                                                    
                                                                                                                                                                                    • Translational efficiency                                     
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DM, disease/deleterious mutations; NM, neutral mutations; HGMD, human gene mutation database; 1000G, 1000 genome project; OMIM, online mendelian inheritance in man; AUC, area under the ROC curve (axes in Eqn. 1).

Available Variant Sets Are Limited in Size and Reliability {#s2_2}
----------------------------------------------------------

Association between genomic variants and diseases can be identified by carefully designed statistical tests, e.g., *via* Genome Wide Association Studies (GWAS) ([@B103]). However, unequivocally identifying variants that cause disease are significantly more difficult; this is a particularly hard problem for sSNVs, which carry no corresponding protein sequence changes. Clinical or experimental validation of the causative relationships between genomic variation and disease is either infeasible altogether (as for polygenic disorders) or exceedingly difficult on a large scale due to the necessary resource and time investments. Instead, computational annotation of genomic variant pathogenicity (or simply functional effects) is a cost- and time-efficient substitute, providing a starting point for further experimental validation and discovery.

Most predictors described here (regSNPs-splicing, DDIG-SN, FATHMM-MKL, and MutationTaster2) collect variants identified as causative (positive) from HGMD. The latest version of HGMD (March 2017) comprises over 203,000 variants in over 8,000 genes, manually curated from scientific literature ([@B97]). Despite its apparent utility, studies have questioned the reliability of HGMD data. [@B30], for example, point out flaws like inconsistent mutation nomenclature and incomplete incorporation of all applicable data. [@B111] note that some mutations in HGMD are named causes of monogenic disease but are not fully penetrant, while [@B5] question disease annotation of recessive variants. In a study of 1,000 exomes, [@B22] note that only 16 of 585 of HGMD disease-causing variants were actually pathogenic, while in a subsequent study with 6,503 individuals, none of the identified 615 HGMD disease-causing variants were pathogenic ([@B1]). Other studies ([@B110]; [@B14]) have shown that many disease-causing variants in HGMD are present in the relatively healthy 1000G individuals ([@B7]).

Other sources of positive training/testing data, including OMIM (used by TraP) and ClinVar (used by TraP, regSNPs-splicing, IDSV, CADD, MutationTaster2, and FATHMM-MKL) ([@B51]), appear no more reliable. Notably, there is considerable inconsistency between the HGMD and OMIM ([@B30]). ClinVar's entries from different sources often conflict between themselves ([@B50]), as the reliability of ClinVar's data curation and workflow of medical interpretation has not been proven ([@B4]). Substantial discordance between ClinVar and laboratory test results has also been reported ([@B33]).

Mutation databases vary drastically ([@B30]), not in the least because of experimental interpretation differences; e.g., roughly 17% of the variant effects reported by different laboratories carry contradictory clinical significance ([@B77]). Labels of pathogenicity are not fixed, switching from disease to benign and back as evidence accumulates ([@B86]). As these binary labels also do not provide a quantitative measure of risk ([@B86]) or penetrance, the term "disease-causing" should be used with caution. One key problem in the field, and a reason for many of the above data limitations, is the absence of a gold standard for identifying disease-causing variants ([@B22]). Moreover, even the "silver-standard" available annotations are far and few between. In fact, while there are many known pathogenic nsSNVs, there are currently much fewer known pathogenic sSNVs available: dbDSM ([@B106]) (including those from ClinVar, PubMed, NHGRI GWAS catalog ([@B105]), etc.) contains 1,289 pathogenic sSNVs, and HGMD contains roughly 900 pathogenic sSNVs ([@B56]). Arguably, this number is too small to build a generalizable model for evaluating tens of millions of the possible synonymous variants in human genome. Note that an additional problem is the absence of a true negative set of variants, i.e., those that have been verified to have no effect on protein function or no relationship to some disease ([@B9]).

Use of Allele Frequency to Approximate Variant Effect {#s2_3}
-----------------------------------------------------

SilVA was trained on 33 experimentally defined deleterious and 785 assumed neutral (observed in 1000G) variants. While the former set was very stringently selected, this small number of samples could hardly produce a generalizable model. Other predictors use less well curated data from available databases, but as such run into a problem of reliability. To supplement the lack of experimentally annotated variation, variant population frequency had been suggested as a sign of effect/pathogenicity; i.e., it is generally assumed that disease/effect variants are of low allele frequency ([@B31]), although the precise threshold for "low" is unclear. Predictors (CADD, DANN, FATHMM-MKL, SilVA, regSNP-splicing) often filter out effect variants of higher frequency and/or neutral variants of lower frequency. CADD and DANN training data, for example, contains simulated human variants, appearing after human-chimpanzee divergence, labelled as the effect group (depleted by natural selection) and observed fixed or nearly fixed derived alleles as neutral ([@B44]; [@B76]). Note although simulated variants are likely enriched in deleterious variants, and CADD scores have been shown useful in prioritizing variants in clinical settings ([@B1]; [@B66]; [@B102]), it is difficult to directly link the CADD predictions to pathogenicity ([@B44]).

Allele frequency, however, is not necessarily correlated with variant effect, particularly when effect being considered is "function change" not "disease." In an earlier study, we found that common \[minor allele frequency (MAF) \> 5%\] non-synonymous variants were more often predicted to have a functional effect than rare (MAF \< 1%) ones ([@B59]). Here a high-frequency allele may be beneficial/advantageous and on the way to becoming common, or slightly deleterious and on its way out ([@B9]). Moreover, trivially, allele frequency estimated from the sequenced genomes may be subject to change as the number of samples increases. Thus, 1) low allele frequency is not equivalent to having an effect and 2) although high frequency alleles are unlikely to be disease causing, they may have some impact. Additionally, and perhaps most fundamentally, note that the currently observed SNVs are unlikely a complete set of naturally occurring variants, i.e., many SNVs may be yet unseen.

Features Used Vary From Predictor to Predictor {#s2_4}
----------------------------------------------

A variety of features have been considered by predictors as described below. Note that the number of features used in existing predictors ranges from 26 (SilVA) to 1,281 (FATHMM-MKL).

### Conservation {#s2_4_1}

Evolutionary conservation, derived from multiple sequence alignments (MSAs) of homologous sequences ([@B68]), is perhaps the most extensively used feature of variant-effect predictors. Commonly used DNA conservation scoring algorithms include GERP ([@B19]), phastCons ([@B93]), and PhyloP ([@B74]) scores. GERP (Genomic Evolutionary Rate Profiling) is a statistical method identifying genomic constrained elements from MSAs. GERP uses a statistical model estimating species divergence times ([@B36]) and a structural expectation maximization algorithm for phylogenetic inference ([@B27]); the later GERP++ is a faster version of the original ([@B20]). phastCons fits MSAs to phylogenetic hidden Markov models to identify conserved elements ([@B93]). The major difference between phastCons and GERP is that the former models the size and distribution of conserved elements within an MSA, while the latter first individually assesses the conservation at a locus and then searches for clusters of highly conserved loci ([@B15]). PhyloP combines statistical tests and GERP to detect conservation and acceleration in nucleotide substitution rates ([@B74]). All variant effect predictors use at least one of these conservation scoring techniques ([**Tables 1**](#T1){ref-type="table"}, [**2**](#T2){ref-type="table"}). DDIG-SN also additionally uses protein conservation as conserved protein positions are often structurally important ([@B67]), suggesting possible misfolding due to decreased rate of translation at the relevant codon. Similarly, sSNVs may lead to mistranslation ([@B47]; [@B48]; [@B46]) resulting in amino acid substitutions---a particularly problematic occurrence at conserved protein positions.

###### 

Summary of generalized SNV predictors.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Ref/Tool name            Training data                                                                                                                                                             Model                                            Features                                Performance
  ------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------ --------------------------------------- ---------------------------------------------------------------------------------------------------
  ([@B44])\                13,141,299 SNVs, 627,071 insertions, and 926,968 deletions from simulated and observed variant sets                                                                       SVM with linear kernel                           63 in total\                            **No testing of synonymous variants**
  CADD (2014)                                                                                                                                                                                                                                          • Conservation\                        
                                                                                                                                                                                                                                                      vVariant consequence\                   
                                                                                                                                                                                                                                                       • DNA features\                        
                                                                                                                                                                                                                                                       • Other                                

  ([@B76])\                13,302,220 observed variants; 13,302,220 simulated variants selected from CADD data                                                                                       Neural network with 3 1,000-node hidden layers   63 features from CADD                   **All types of variants, amount of sSNVs not stated**\
  DANN (2014)                                                                                                                                                                                                                                                                                 **Dataset**: 162,777 observed and 162,777 simulated variants (including synonymous variants).\
                                                                                                                                                                                                                                                                                              **Result**: Overall accuracy = 0.66

  ([@B92])\                1,073 coding DM from HGMD and 1,073 coding NM from 1000G for 10-feature-group model; 3,000 coding DM from HGMD and 3,000 coding NM from 1000G for 4-feature-group model   Multiple kernel learning                         1,281 in total\                         **Coding variants, amount of sSNVs not stated**\
  FATHMM-MKL (2015)                                                                                                                                                                                                                                    • Conservation\                        **Dataset**: 5-fold cross-validation from training data\
                                                                                                                                                                                                                                                       • DNA properties\                      **Result**: AUC = 0.93 and 0.91for 10-feature-group model and 4-feature-group model, respectively
                                                                                                                                                                                                                                                       • Other                                

  ([@B83])\                122,238 DM from ClinVar and HGMD; 6,807,269 NM from 1000G                                                                                                                 Bayesian classifier                              ∼ 7 (not explicitly stated) in total\   **No testing of synonymous variants**
  MutationTaster2 (2014)                                                                                                                                                                                                                               • Conservation\                        
                                                                                                                                                                                                                                                       • DNA properties\                      
                                                                                                                                                                                                                                                       • Splicing                             
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DM, disease/deleterious mutations; NM, neutral mutations; HGMD, human gene mutation database; 1000G, 1000 genome project; AUC, area under the receiver operating characteristic curve.

Conservation is a very important signature of variant effect. For example, for ClinVar's missense dataset the solely-conservation-based component of CADD, GerpS (a derivative of GERP++), as well as PhastCons and PhyloP, attained ROC AUCs (area under the receiver operating characteristic curve) of over 0.82, while CADD's ROC AUC was only slightly higher (0.93) ([@B44]). In FATHMM-MKL's cross-validation on coding variants, its ROC AUCs was = 0.93 while the ROC AUCs for conservation scores alone was = 0.91 ([@B92]). Similar results are observed for DDIG-SN (DDIG-SN's ROC AUCs = 0.85, PhyloP's ROC AUCs = 0.76) ([@B56]) and TraP (TraP's ROC AUCs = 0.88, GERP++'s ROC AUCs = 0.87) ([@B29]) datasets. These results suggest that over billions of years of evolution, nature's laboratory has tested and discarded most of the detrimental variants. However, it is important to note that functional tuneability, i.e., development of new or environment-specific versions of functions is an ongoing process, which requires the presence of variants in positions of all levels of conservation, in any given snapshot of a population ([@B63]; [@B64]).

### DNA Properties {#s2_4_2}

The DNA properties describing the biological effects of sSNVs include but are not limited to localization to transcription factor (TF) binding sites, overall GC content of genes and genomes, and CpG island locations (cytosine followed by guanine in 5' to 3' direction). In more detail: many studies have shown that coding exons can serve as regulatory elements for transcription ([@B52]; [@B41]); i.e., roughly 15% of the human genome codons both code for amino acids and specify TF recognition ([@B99]). Thus, synonymous variants in TF-relevant codons can affect TF binding and alter gene transcription rates. Exonic and the flanking intronic region GC architectures can affect DNA methylation and exon recognition ([@B28]). Additionally, CpG sites often host DNA methylation ([@B6]), playing an important role in gene transcription ([@B28]). As mutation rates at CpG dinucleotides are an order higher than at other sites ([@B65]), sSNVs can thus alter methylation patterns by disrupting site-specific GC architectures.

All predictors covered in this manuscript, except regSNPs-splicing, incorporate one or more of these DNA properties ([**Tables 1**](#T1){ref-type="table"}, [**2**](#T2){ref-type="table"}).

### RNA Properties {#s2_4_3}

*Codon bias*. The preference (frequency of use) of particular codons by specific organisms or tissues is termed codon bias. Codon bias correlates with and informs gene expression levels ([@B16]; [@B13]; [@B23]; [@B8]; [@B46]), translation rate ([@B95]), as well as protein structure ([@B115]) and cotranslational folding ([@B72]; [@B10]). There are many different metrics describing codon bias including codon adaptation index ([@B88]), synonymous codon usage order ([@B2]), relative synonymous codon usage ([@B88]), etc. Surprisingly, only SilVA and DDIG-SN have considered codon bias as a factor in their models ([**Table 1**](#T1){ref-type="table"}).

A related factor governing translation rate is the supply of tRNA during translation. Note that tRNA concentrations are different across organisms and that some organisms lack certain tRNA altogether, supplementing the necessary functionality *via* third position wobble ([@B69]). It is hypothesized that codon composition in coding regions coevolved with tRNA abundances to reach the desired translation rates ([@B73]). tRNA adaptation index (tAI) ([@B78]), used only by IDSV ([**Table 1**](#T1){ref-type="table"}), is a measure aimed to describe codon bias from the perspective of tRNA supply and demand.

A potentially important feature also missing from all predictors is codon autocorrelation. In codon autocorrelated sequences, same codons follow each other in sequence, i.e., sequence AAABB is more autocorrelated (less anticorrelated) than sequence ABABA, where A and B are two codons of the same amino acid ([@B12]). Autocorrelated yeast transcripts are translated faster than anticorrelated ones ([@B12]) and many prokaryotes modulate translation through codon correlation ([@B34]). Thus, using codon correlation may help characterizing sSNV effect.

*mRNA structure, stability, and abundance*. sSNVs can alter mRNA secondary structure, thus impacting translational efficiency and mRNA decay rate ([@B39]), which, in turn, impacts protein production ([@B46]) and abundance ([@B60]). mRNA sequences are more stable than random collections of nucleotides ([@B84]), suggesting that mRNA stability is evolutionarily selected to accommodate sufficient levels of translation before decay. The secondary structure of mRNAs harbors conserved elements ([@B62]) and is tightly interwoven with GC content and codon usage. In fact, an earlier study found that 26% of the expressed genes display differential mRNA stability across individuals ([@B24]). In these genes, higher GC3 (G or C at the third position of the codon) percentage correlated with higher mRNA stability. This finding is in line with the fact that among the different SNVs, G and C alleles generally result in higher mRNA stability than A and T alleles ([@B24]). Furthermore, stability is enhanced in mRNA sequences enriched in optimal codons corresponding to tRNAs of higher concentrations ([@B75]).

A number of *in silico* tools have been developed to predict the mRNA structure and stability, including mFold (UNAFold) ([@B116]; [@B61]), remuRNA ([@B80]), KineFold ([@B107]), and RNAfold (ViennaRNA package) ([@B37]). Note, however, that RNA molecules are very thermodynamically flexible and can take on many possible structures. Thus, the predicted RNA structure and its stability depend on the pre-set prediction strategy, which can be aimed to find the minimum free energy structure, the structure closest to other possible structures, or to maximize expected prediction accuracy, which is difficult for RNAs longer than 500 nucleotides ([@B58]). Consequentially, the prediction of RNA structure and stability is inherently uncertain. Among all the sSNV predictors, only SilVA and DDIG-SN use predictive tools to compute the variant-induced changes of energy and structures in pre-mRNA and mature mRNA sequences ([**Table 1**](#T1){ref-type="table"}).

Note that sSNVs, as well as other variant types ([@B87]), are particularly relevant to functionality of highly expressed genes. Thus, the Genotype-Tissue Expression (GTEx) project's database containing large-scale human tissue-specific gene expression data ([@B57]) can be used to establish genes that are likely to manifest sSNV effect. However, none of the predictors described here use expression information to inform their effect predictions.

### Splicing Properties {#s2_4_4}

mRNA splicing is a major predictive feature in some predictors, especially regSNPs-splicing and IDSV. It is estimated that up to 15% of disease SNVs cause aberrant splicing ([@B49]). sSNVs can impact exonic splicing enhancers (ESEs) and silencers (ESSs), i.e., short DNA sequence motifs that promote or suppress splicing of pre-mRNA by binding to SR proteins (proteins with long repeats of serine and arginine) ([@B104]). Moreover, sSNVs can change the affinity of pre-mRNA to spliceosomes, leading to false recognition of exon-intron boundaries and producing abnormal mRNAs and dysfunctional proteins ([@B3]). Taken together, the sSNVs' potential of disrupting splicing is the likely reason for slower evolution at within-ESE sites ([@B71]).

Predictors describe the potential impact of sSNVs on splicing by relying on the identified putative ESE and ESS motifs. Identification of these motifs and the corresponding splicing regulatory proteins has been an ongoing experimental and computational effort ([@B104]; [@B90]); identified motifs and regulatory proteins are available *via* public repositories ([@B21]; [@B32]; [@B108]). Tools such as SPANR (Splicing-based Analysis of Variants) ([@B109]), have also been developed to predict the splicing effects of SNVs. Splicing is considered by all sSNV-specific predictors, although represented *via* different values.

### Protein Properties {#s2_4_5}

One often overlooked aspect in evaluating sSNV effect is the protein structure. Rare codon variants of frequent synonymous codons may slow down the translation rate due to low concentration of tRNAs, slow or stop the elongation of the peptide chain ([@B112]), and influence co-translational folding ([@B43]; [@B72]). Cotranslational folding is closely related to the formation of protein secondary and tertiary structures ([@B38]); alpha-helix formation can occur in the ribosomal tunnel ([@B45]), while tertiary structure formation may take place before the protein completely exits the ribosome ([@B113]). Translationally fast codons are enriched for alpha helices, while beta strands and coil regions prefer translationally slow codons ([@B101]). Optimal codons are enriched in buried and structurally important sites but are negatively correlated with solvent accessible sites ([@B115]). Pathogenic sSNVs are generally enriched within the buried sites, intrinsic disorder regions, and alpha-helices, as well as in exons overlapping with known or predicted protein family domains ([@B114]). These findings suggest that protein structure should be considered when modelling the effects of sSNVs. However, only regSNPs-splicing and DDIG-SN predictors incorporate protein structural information ([**Table 1**](#T1){ref-type="table"}).

Evaluation of the Predictors {#s3}
============================

Collecting the Evaluation Data Set {#s3_1}
----------------------------------

sSNV effect predictor evaluation is hampered by three major problems: 1) there is no clear definition of neutral and effect variants and 2) available neutral/effect experimental evaluations are limited, and 3) most have been used in predictor development. Here, we created our own data set of variants for evaluation purposes as follows: we collected the *observed* sSNVs \[all non-singleton sSNVs that have been observed in either 1000G, ExAC ([@B53]), or gnomAD ([@B40])\] and the *generated* sSNVs (all possible sSNVs in human genes, excluding *observed* and singleton sSNVs); we thus extracted 1,362,607 *observed* and 24,008,961 *generated* sSNVs. For evaluation purposes, we randomly selected 1,362,607 *generated* variants from our set to create a balanced *observed/generated* variant *Test set* (details in [**Supplementary Material**](#SM1){ref-type="supplementary-material"}).

There are multiple equally valid reasons for why nearly 95% of all possible sSNVs are not *observed*; the most obvious ones are technical, i.e., insufficient data or sequencing technology bias, and evolutionary, i.e., purifying selection, genetic drift, and genetic hitch-hiking ([@B94]). As per the latter, we assume that drastically deleterious variants, which would be eliminated on a population scale due to purifying selection, are significantly more frequent in the set of *generated* sSNVs than in *observed* ones. However, the former suggests that we may have simply not (yet) sequenced many of the un-observed *(generated)* variants, which are actually equivalent in potential effect to *observed* ones. Notably, since a large proportion of discovered sSNVs are singletons ([@B53]), an equivalent proportion of similarly neutral or mild-effect variants can likely be found on the other side of the "sequencing barrier," i.e., they have yet to be sequenced. Moreover, different categories of variants vary in the likelihood of being observed. For example, according to the ExAC project, the discovery of CpG transitions (C- \> T, where C is followed by G) is likely close to saturation, while additional transversion and non-CpG transitions are yet to be identified ([@B53]).

We observe that 1) most of the large effect variants are likely in the *generated* set and either 2a) they make up much of that set, i.e., the *generated* set contains mostly effect variants, or 2b) there are relatively few of them, i.e., the distribution of effect and neutral variants is roughly equivalent across the *generated* and *observed* variants. Note that if (2a) is true, we expect that a precise and sensitive sSNV effect predictor should be able to differentiate the *observed* sSNVs from the *generated* ones, while (2b) would mean that the same predictor would produce similar effect distributions.

Note that our *Test set* data are collected in a somewhat similar, but ultimately very different, way as CADD's (and DANN's) training data. CADD's observed variants are the fixed or nearly fixed alleles at sites where human genes are different from the inferred human-chimpanzee ancestor and thus may encompass our excluded *observed* singletons. CADD's simulated variants follow an estimated *de novo* mutation rate since human-chimpanzee divergence, and thus are a subset of all our variants, including *generated, observed*, and singletons. Importantly, even with down-sampling of *generated* variants to create a balanced set, our *Test set* is much larger (∼2.8 million) and more broadly defined than CADD's strictly curated training set (∼100,000).

We calculated the enrichment of *observed* sSNVs relative to *generated* sSNVs separately by amino acid ([**Figure 2A**](#f2){ref-type="fig"}) and codon ([**Figure 2B**](#f2){ref-type="fig"}) type. We observe that the distribution of naturally occurring sSNVs is non-random across amino acids and codons. Thus, over a fifth of all tyrosine (Y) and histidine (H) codons in our genome is affected by sSNVs, as compared to roughly 8% of lysine (K) codons. Curiously, the most mutated codons are threonine ACG, serine TCG, and proline CCG (\> 43% of each is affected by an sSNV) and alanine GCG (37%). Thus, the CG end-of-codon nucleotide pair seems to indicate least stable codons. On the other hand, the isoleucine ATA codon is almost never mutated (∼1%), suggesting that it is preferentially maintained as error free. Moreover, the enrichments of observed sSNVs by amino acids (or codon) are not proportional to the abundance amino acids (or codon) in human transcriptome. The amino acids (e.g., Y, H, N, D) and codons (e.g., ACG, TCG, CCG, GCG, TAC, CAC) with high enrichment of *observed* sSNVs are those of low abundances. This decidedly non-random distribution of variants across codons and amino acids strongly suggests that our *generated* and *observed* variants are likely indeed different from the evolutionary, and thus likely effect, perspective.

![Ratios of *observed* and *generated* sSNVs vary across codons and amino acids. Ratios of *observed* to *generated* sSNVs (barplot, left axis) affecting specific **(A)** amino acids and **(B)** codons in the human transcriptome differ. Lines (right axis) in plots indicate the fractions of **(A)** amino acids and **(B)** codons ("\*" is a stop codons). Trivially, 2-codon amino acids are generally enriched for *observed* sSNVs, while higher degeneracy codons are depleted. However, there is a significant difference between the most and least frequent 2-codon amino acid sSNVs. Codons with an NCG pattern (N = any nucleotide) are most often affected by sSNVs. On the other hand, codons with a CGN pattern (also CpG) are relatively rarely affected. Note that amino acid degeneracy is correlated with % composition, although a single codon is often responsible for coding most of each of these amino acids (e.g. Leucine CTG and Valine CTG).](fgene-10-00914-g002){#f2}

Predictors Do Not Distinguish *Observed* and *Generated* sSNVs {#s3_2}
--------------------------------------------------------------

To the best of our knowledge, our collection of tools (CADD, DANN, MutationTaster2, FATHMM-MKL, SilVA, TraP, DDIG-SN, regSNP-splicing, and IDSV) make up a complete set of publicly available methods for sSNV analysis. We first evaluated ([**Figure S2**](#SM1){ref-type="supplementary-material"}) the ability of all predictors (except regSNP-splicing, which was not functional at the time of writing) to differentiate 50,000 *observed* and 50,000 *generated* sSNVs ([**Supplementary Materials**](#SM1){ref-type="supplementary-material"}). We did not include IDSV for more further analysis because its performance was similar to that of other predictors and it was not available for running it locally or online for the entire set of our variants. Unfortunately, we also had to exclude MutationTaster2, which experienced server problems when running large batches of data.

We used CADD, DANN, FATHMM-MKL, SilVA, TraP, and DDIG-SN to make predictions for our complete variant *Test set*. We calculated the fraction of consensus binary predictions ([**Figure 3A**](#f3){ref-type="fig"}) (FCBP; i.e., the number of predictions agreed upon) for all pairs of predictors and the correlation between scores ([**Figure 3B**](#f3){ref-type="fig"}). As per CADD creators (<https://cadd.gs.washington.edu/info>), it is hard to threshold its raw scores, while the recommended neutral/deleterious cutoff for phred-scaled scores is 15. For the rest of the predictors, we used 0.5 as the binary threshold (\> 0.5 is deleterious). We observed ([**Figure 3A**](#f3){ref-type="fig"}) that the CADD and other sSNV-specific predictors agree with each other because their scores are mostly low ([**Figures 3F--H**](#f3){ref-type="fig"}). Scores from general-purpose predictors do not have high correlation with sSNV-specific predictors. Meanwhile, DANN and FATHMM-MKL did not agree with others or between themselves. This lack of agreement across the *Test set* indicates that, in the best case, predictors are orthogonal, correctly identifying a different subset of variants each or, in the worst case, they are mostly unable to recognize effect. Curiously, for each predictor, the distributions of sSNV scores of *observed* and *generated* variants were very similar ([**Figure 3**](#f3){ref-type="fig"}), i.e., predictors disagreed between themselves and with our dataset labels. Note that since the data is large, statistical tests to establish their difference could easily achieve significance and may not be meaningful ([@B42]). Instead, we directly evaluated predictor ability ([**Table 3**](#T3){ref-type="table"}) to differentiate the two types of variants using ROC AUCs. ROC curve is a plot of true positive rate (TPR) against false positive rate (FPR), which are computed with true positive (TP), false negative (FN), and false positive (FP) (Eqn. 1). No predictor was able to accurately differentiate *generated* and *observed* variants well. To evaluate the variation of different predictors introduced by the sampling of the *generated* set, we also subsampled the *observed* and *generated* sets for 20 times (each with 100,000 samples) and calculated the resulting standard errors of ROC AUCs ([**Table 3**](#T3){ref-type="table"}).
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![Predictor scores correlate somewhat, but do not differentiate *observed* vs. *generated* sSNVs. Panel **(A)** shows the amount of agreement (i.e., FCBP) for any pair of predictors. High FCBP values indicate that two predictors agree in assigning binary (neutral/deleterious) predictions to variants. Panel **(B)** shows the Pearson correlations among the prediction scores. **(C**--**I)** Violin/box plots of prediction score distributions across predictors: CADD raw, CADD phred-scaled, DANN, FATHMM-MKL, SilVA, TraP, and DDIG-SN, respectively.](fgene-10-00914-g003){#f3}

###### 

AUCs of the predictors on sSNVs and nsSNVs.

                            *Observed* vs. *generated* sSNVs   *Observed* vs. *generated* nsSNVs   
  ------------------------- ---------------------------------- ----------------------------------- -------
  CADD raw score            0.518                              0.517±0.0012                        0.564
  CADD phred-scaled score   0.518                              0.518±0.0013                        0.564
  DANN                      0.506                              0.506±0.0023                        0.491
  FATHMM-MKL                0.540                              0.540±0.0013                        0.555
  SilVA                     0.527                              0.527±0.0009                        
  TraP                      0.495                              0.496±0.0038                        
  DDIG-SN                   0.535                              0.535±0.0012                        

\*Test set was sampled 20 times (each with 100,000 observed and 100,000 generated variants) to produce averages and standard deviations (SD) of AUCs for sSNVs.

Predictor Performance Is Only Slightly Better for nsSNVs Than for sSNVs {#s3_3}
-----------------------------------------------------------------------

As mentioned previously, the unexpected inability of predictors ([**Figure 3**](#f3){ref-type="fig"}) to differentiate *observed* and *generated* variants may indicate either the inappropriateness of the data set for the evaluation task or limited predictor abilities. The latter may be related to the specific variant type; i.e., general-purpose predictors, such as CADD and FATHMM-MKL, are good at analyzing non-synonymous variants ([@B44]; [@B92]), but they may be less sensitive to effects of synonymous variants. To evaluate this possibility, we randomly selected 500,000 each *observed* and *generated* non-synonymous variants from dbNSFP ([@B54]; [@B55]) and extracted their associated predictor scores (see [**Supplementary Material**](#SM1){ref-type="supplementary-material"}). Briefly, an nsSNV was considered *observed* if it was reported by either 1000G, ExAC, or gnomAD; otherwise it was deemed a *generated* nsSNV. While some of the predictors were slightly better at differentiating *generated* from *observed* nsSNVs ([**Figure 4**](#f4){ref-type="fig"}, [**Table 3**](#T3){ref-type="table"}) than sSNVs, their performance was still not up to the expectations. We also calculated FCBP ([**Figure 4A**](#f4){ref-type="fig"}; cutoffs as above) and score correlation ([**Figure 4B**](#f4){ref-type="fig"}) to find that CADD, DANN, and FATHMM-MKL have a considerably higher agreement on nsSNVs than on sSNVs ([**Figure 3A**](#f3){ref-type="fig"}).

![Predictor scores correlate, but do not clearly differentiate *observed* vs. *generated* nsSNVs.Panel **(A)** shows the amount of agreement (i.e., FCBP) for any pair of predictors. High FCBP values indicate that two predictors agree in assigning binary (neutral/deleterious) predictions to variants. Panel **(B)** shows the Pearson correlations among the prediction scores. **(C**--**F)** Violin/box plots of prediction score distributions across predictors: CADD raw, CADD phred-scaled, DANN, and FATHMM-MKL, respectively.](fgene-10-00914-g004){#f4}

Inferring a Predictor Scoring Threshold From Prediction of Common Variant Effects {#s3_4}
---------------------------------------------------------------------------------

The predictor inability to differentiate *observed* and *generated* variants may also be due to the difficulty of defining effect threshold; i.e., variants of low effect are harder to precisely annotate, both computationally and experimentally, and can be equally well classified as effect or neutral. In an effort to increase resolution between the two, predictors often link high allele frequency to absence of effect. In fact, CADD, DANN, FATHMM-MKL, SilVA, and regSNP-splicing effectively label high allele frequency variants as neutral. Taken further, TraP scores were reported ([@B29]) to have negative correlation (−0.51) with bin-average ExAC allele frequencies ([@B53]). Note that, as mentioned above, this reasoning side-steps evolutionary flow where common (not yet fixed or removed) variants may be advantageous or damaging. To further elaborate on allele frequency relationship with effect predictions, we obtained frequency data from multiple sources (1000G, ExAC, and gnomAD, see [**Supplementary Material**](#SM1){ref-type="supplementary-material"}) for our *observed* variants. Notably, we saw no correlation, positive or negative, between allele frequency and any predictor score ([**Figure 5**](#f5){ref-type="fig"}). This observation highlights predictor binary classification abilities rather than a continuous spectrum of effect.

![Some predictors assign higher scores to rare variants. In all panels, the scatterplots display the density of *observed* variant prediction scores *vs.* log~10~(allele frequency). A scoring threshold (red dashed line) for each predictor identifies scores above the threshold as reliable. The threshold is placed at the score that is higher than 99% of common (allele frequency \> 0.01) variant scores. **(A**-**G)** represents the scatterplot for CADD raw, CADD phred-scaled, DANN, FATHMM-MKL, SilVA, TraP, and DDIG-SN, respectively.](fgene-10-00914-g005){#f5}

For some of the predictors (CADD, SilVA, TraP, DDIG-SN) high scoring variants were overwhelmingly of low frequency. At the same time, many of the low frequency variants were low scoring. Assuming that the predictor scores can be used as reliable indicators of common variant neutrality (low scoring), this result reinforces the idea that low frequency variants are as likely to be pathogenic/effect as neutral/benign. Furthermore, common variant score distributions could help approximate the predictor thresholds of effect. Thus, while variants scoring above a certain threshold can be considered to have an effect, below this threshold binary predictor resolution is questionable.

Predictor thresholds were chosen as the score below which most (99%) of the common variants (allele frequency \>0.01) reside ([**Figure 5**](#f5){ref-type="fig"}). Thus, scores above this threshold indicate effect, while scores below the threshold could be effect or neutral. We further applied the selected thresholds to both *observed* and *generated* sSNVs ([**Table 4**](#T4){ref-type="table"}). We define *resolution* (Eqn 2, where "N" stands for number) as a predictor's ability to capture the enrichment of deleterious variants above threshold.
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###### 

Percentage of sSNVs scoring above threshold and the corresponding predictor resolutions.

                            \% Above-the-threshold sSNVs in *observed*   \% above-the-threshold sSNVs in *generated*   Resolution
  ------------------------- -------------------------------------------- --------------------------------------------- ------------
  CADD raw score            0.871                                        1.981                                         2.274
  CADD phred-scaled score   0.868                                        1.979                                         2.280
  DANN                      1.594                                        2.156                                         1.352
  FATHMM-MKL                1.639                                        2.522                                         1.538
  SilVA                     4.902                                        6.015                                         1.227
  TraP                      2.376                                        2.912                                         1.226
  DDIG-SN                   1.764                                        2.414                                         1.368

The *resolutions* were greater than one for all the predictors, with CADD attaining the highest resolution (\> 2). Note that only a small fraction of variants in both sets scored above the threshold, but since the total number of *generated* variants is nearly 18 times higher than the number of *observed* variants, the estimated number of potential identifiably-deleterious sSNVs is only an order of magnitude less than ALL observed sSNVs (∼475K vs. ∼1.3M). These results suggest that the *generated* set indeed contains many more deleterious variants than the *observed* set and that a new predictor train to recognize these differences may identify deleterious variants more reliably than existing methods.

Conclusion {#s4}
==========

Training data is perhaps the most critical component for a machine learning-based variant-effect-predictor. Most sSNV effect predictors we reviewed, retrieved training data from disease mutation databases, such as HGMD and ClinVar. Disease-causing variants can be thought of as severely functionally deleterious, although non-disease variants could also be deleterious or beneficial. Moreover, identifying an sSNV as disease causing, as opposed to associated with disease, is extremely difficult, if not impossible. In fact, studies have revealed flaws of existing disease mutation databases, which may further undermine the reliability of the contained data. Progress in saturation genome mutagenesis may improve data availability in the near future. Currently, however, there is no publicly available, sufficiently large collection of variants with experimentally validated effect annotations that can be used for building a generalizable sSNV effect-predictor.

The lack of gold standard data also prevents proper evaluation of the predictors. Here, we proposed a *Test set* of *observed*and *generated* sSNVs. We assumed that the *generated* set is enriched for deleterious sSNVs due to purifying selection and expected the predictors to differentiate these from the *observed* variants. However, the predictor performance on this data was below our expectations. Note that predictor scores for the variants in our set were poorly correlated and the amount of binary prediction agreement was limited. This observation suggests that predictions may be biased by shared input features, but do not sufficiently well indicate variant effect. We proposed a scoring threshold to separate reliable predictions from the highly uncertain ones for each of the predictor. With the thresholds identified, we further observed that all predictors had significantly more reliably identified sSNVs in the *generated* set than in *observed* set, in line with our earlier expectations of the quality and contents of the *Test* set. However, the inability of the predictors to clearly identify effect variants below the severity threshold, suggests that more work is necessary to understand sSNV effects.

We note that our *Test set* is not a gold-standard testing set and is only appropriate for predictor testing only if our underlying biological/data distribution assumptions hold. Thus, we cannot make concrete recommendations of best-practice prediction tools. However, our results clearly indicate that the predictions are highly correlated across sSNV-specific methods, i.e., there is little difference between using SilVA, DDIG-SN, or TraP. On the other hand, outputs of general purpose-predictors (CADD, DANN, and FATHMM-MKL) do not correlate as well. Of these, CADD phred-scaled scores are least likely to classify common variants as having a large effect; i.e., CADD high scores may be deemed reliably non-neutral. Note, however, that this does not mean that CADD low scores indicate variant neutrality -- a necessary distinction that evades much of the variant effect literature.

Looking forward to a future sSNV effect-predictor, we note that comparing *observed* vs. *generated*, rather than effect vs. no-effect, variants drastically increases the amount of data useful for training. We also note that this variant collection will need further filtering to address the problem of false positives, i.e., the yet-to-be-*observed generated* variants. Moreover, the transition from *observed* to no-effect and from *generated* to effect annotations will not be trivial. As mentioned earlier, while severe effect variants are likely predominantly confined to the *generated* set, the mild effect variation is probably distributed throughout both *observed* and *generated* collections. Despite these difficulties, the observation that existing predictors identify more higher-scoring effect variants in the *generated* data, suggests that the effect signal can indeed be learnable by models trained to differentiate *observed* vs *generated* variants. Thus, a model using the previously mentioned set of features, possibly in combination with an ensemble of (orthogonal, as evaluated above) existing classifiers, may provide a more reliable description of variant effects.
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